FDA grants accelerated approval to rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer
Hematology / Oncology News Burst
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Grants | Hematology | Prostate Cancer